12 O’Clock High, a podcast on business leadership: Building Trust and Relationships: The Power of Compliance and Ethics with Jacqui Pruet
Marketing Minute Video with NP Strategy: Mastering Stakeholder Engagement
Monthly Minute | ESG—Integrating Public Policy Engagement
[Webinar] Impact and ESG in the Cannabis Industry
Infrastructure and Indigenous Engagement
Compliance Perspectives: Rolling Out New Compliance Initiatives
Episode 22: Social Impact Programs: Why Purpose Makes a Difference
Measures of success: How value-based pricing may change the pharmaceutical industry
FCPA Compliance Report-Episode 330 Robin Bew and Henry Stoever of the NACD
I’m not well-versed in antitrust law – nor do I want to be – but this recent FTC/DOJ Statement of Interest from the antitrust lawsuit filed by the State of Texas against BlackRock, State Street and Vanguard bears on...more
On 8 May 2025, the European Commission (“the Commission”) launched two public consultations as part of its comprehensive review of the guidelines for horizontal and non-horizontal mergers. ...more
Global M&A in 2024 faced geopolitical issues, elevated interest rates, and inflationary pressures, with expanding antitrust, foreign investment, national security, and export regimes adding complexity. But inflation receded...more
Most of the potential complications and outcomes outlined above were not considered by the US Congress and other WTO members, which previously considered only conventional businesses competing among themselves when drafting...more
Citing its priority to facilitate the timely development and approval of generic drugs, the U.S. Food and Drug Administration ("FDA") solicits stakeholder input on the types of patents that should be listed in the Orange...more